Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04554147
Other study ID # 19-009247
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 15, 2021
Est. completion date June 30, 2023

Study information

Verified date April 2024
Source Mayo Clinic
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The project objective is to test the feasibility of delivering health education and self-management support to African-American patients with uncontrolled hypertension (HTN) through a culturally-tailored smartphone application (app)-enhanced intervention within federally qualified health centers.


Description:

The Fostering African-American Improvement in Total Health (FAITH!) Program at Mayo Clinic, a community-based cardiovascular (CV) health promotion initiative for African-Americans (AAs) will collaborate with the Minnesota Department of Health (MDH) Cardiovascular Health Unit and two federally qualified health centers (FQHCs) (NorthPoint Health & Wellness Center, Minneapolis, MN; Open Cities Health Center, St. Paul, MN) to integrate an innovative mobile health (mHealth) intervention (FAITH! HTN App) into clinical and community settings with the aim of improving blood pressure (BP) control. The project objective is to test the feasibility of delivering health education and self-management support to African-American patients with uncontrolled hypertension (HTN) through a culturally-tailored smartphone application (app)-enhanced intervention within federally qualified health centers. This initiative is a component of a Centers for Disease Control and Prevention (CDC) effort to support state/local public health strategies to prevent and manage cardiovascular disease (CVD) in under-resourced populations disproportionately affected by CVD risk factors, such as HTN. Insights from the FAITH! Community Steering Committee (CSC) will also provide guidance to ensure project patient-centeredness. The investigators will incorporate strategies grounded in theoretical frameworks to ensure soundness of our intervention while tailoring it to meet the preferences and needs of an under-resourced population with multi-level barriers to HTN management. Specific Aim 1:To assess app feasibility through participant intervention engagement (app education module completion, self-monitoring) and intervention satisfaction. Specific Aim 2: To assess preliminary efficacy of the app by evaluating improvement in patient BP control (immediate, 3 months and 6 months post-intervention), CV health knowledge (via app self-assessments), and BP self-management (medication adherence). Hypothesis: The study hypothesis is that an app-based intervention will be feasible and demonstrate preliminary efficacy in improving uncontrolled HTN and health education among AA patients from baseline to post-intervention (immediate, 3 months and 6 months post-intervention).


Recruitment information / eligibility

Status Completed
Enrollment 16
Est. completion date June 30, 2023
Est. primary completion date August 25, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - African American race/ethnicity - 18 years or older - Receive primary care at one of the two partnering Federally Qualified Health Centers (FQHC) and intent to continue care there for next 6 months - Uncontrolled HTN (defined as BP =140/90 mmHg [as per JNC7 Hypertension Guidelines68] at most recent outpatient evaluation, with or without BP medications) - Documented diagnosis of HTN in EHR - At least 1 office visit at one of the two partnering FQHCs in prior year - Smartphone ownership (supporting iOS or Android Systems) Exclusion Criteria: - Unable to commit to participating in both focus groups (pre and post app refinement). - Diagnosis of a serious medical condition or disability that would make participation difficult (i.e. visual or hearing impairment, mental disability that would preclude independent use of the app).

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
FAITH! App-enhanced Hypertension Intervention
FAITH! HTN App: The program promotes HTN self-management through a 10-week education module series on HTN. Participants will follow each module weekly and use a wireless home BP monitor for self-tracking which syncs to the app. The app includes module quizzes, a BP tracking dashboard and a moderated sharing board to foster discussion on HTN management. Patient-Provider-CHW ICM. The patient-provider-CHW triad works together for personalized, collaborative goal setting. The patient will complete app modules, self-monitor BP, and engage with a sharing board integrating HTN topics. At weekly virtual visits (telephone or video), the CHW will record patient BPs, assist with addressing social determinants of health (SDOH) identified by the patient (eg, local community resources), and review HTN modules. The CHW will upload clinical/SDOH data to the patient electronic medical record (EMR) for FQHC care providers to review. This cycle will be completed weekly over the 10-week intervention.

Locations

Country Name City State
United States North Point Health & Wellness Center Minneapolis Minnesota
United States Mayo Clinic Rochester Minnesota
United States Open Cities Health Center Saint Paul Minnesota

Sponsors (1)

Lead Sponsor Collaborator
Mayo Clinic

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Intervention Feasibility Measures - Participant Engagement with Sharing Board Participant engagement with sharing board measured by number of posts per week by each participant Immediate post-intervention
Other Intervention Feasibility Measures - Participant Engagement with Sharing Board Participant engagement with sharing board measured by number of posts per month by each participant 3 months post-intervention
Other Intervention Feasibility Measures - Participant Engagement with Sharing Board Participant engagement with sharing board measured by number of posts per month by each participant 6 months post-intervention
Other Intervention Feasibility Measures - Participant Engagement with Modules Participant engagement with education modules measured by number of modules completed out of 10 Immediate post-intervention
Other Intervention Satisfaction Measures - Participant Satisfaction with FAITH! HTN App Participant satisfaction with FAITH! HTN App measured by the Health Information Technology Usability Evaluation Scale (Health-ITUES). 20 items are assessed, each on a 5-point scale ranging from 1 (strongly disagree) to 5 (strongly agree). A higher total sum indicates higher perceived usability of the technology. Immediate post-intervention
Primary Blood pressure (systolic and diastolic, mmHg) Change from baseline blood pressure. 0 months post intervention
Primary Blood pressure (systolic and diastolic, mmHg) Change from baseline blood pressure. 3 months post intervention
Primary Blood pressure (systolic and diastolic, mmHg) Change from baseline blood pressure. 6 months post intervention
Primary Intervention Feasibility Measures - Participant Engagement with Self-Monitoring Participant engagement with weekly blood pressure tracking measured by number of times participant engaged with the blood pressure feature Immediate post-intervention
Primary Intervention Feasibility Measures - Participant Engagement with Self-Monitoring Participant engagement with weekly blood pressure tracking measured by number of times participant engaged with the blood pressure feature Time Frame: 3 months post-intervention
Primary Intervention Feasibility Measures - Participant Engagement with Self-Monitoring Participant engagement with weekly blood pressure tracking measured by number of times participant engaged with the blood pressure feature Time Frame: 6 months post-intervention
Primary HTN Self-Care Measures - Participant HTN self-care activities using the H-SCALE (Hypertension Self-Care Activity Level Effects) The 31-item instrument assess 6 HTN behavioral self-care activities recommended for optimal HTN management Immediate post-intervention
Primary HTN Self-Care Measures - Participant HTN self-care activities using the H-SCALE (Hypertension Self-Care Activity Level Effects) The 31-item instrument assess 6 HTN behavioral self-care activities recommended for optimal HTN management 3 months post-intervention
Primary HTN Self-Care Measures - Participant HTN self-care activities using the H-SCALE (Hypertension Self-Care Activity Level Effects) The 31-item instrument assess 6 HTN behavioral self-care activities recommended for optimal HTN management 6 months post-intervention
Secondary Preliminary Efficacy of Intervention - CV Health Knowledge as measured by module assessment scores Change in percentage correct scores (pre- and post- self-assessments) for each education module by patient and as a conglomerate (mean) for all patients. Immediate post intervention
Secondary Social Determinants of Health (SDOH, PRAPARE (Protocol for Responding to and Addressing Patient Assets, Risks, and Experiences) tool) Change from baseline PRAPARE score. The PRAPARE assessment tool will be used to calculate a tally risk score indicating the cumulative number of SDOH risks a patient faces (including 15 SDOH domains). Immediate post-intervention
Secondary Preliminary Efficacy of Intervention - BP Self-Management: Self-efficacy for HTN management Change from baseline score. Self-efficacy to change health behaviors to manage HTN as measured by a 5-item instrument. Immediate post-intervention
Secondary Self Efficacy for Medication Adherence as measured by the MASES scale (medication adherence self-efficacy scale) Change from baseline score. The 13-item instrument assesses patients' confidence in their ability to take their BP medications in a variety of situations. Immediate post-intervention
See also
  Status Clinical Trial Phase
Completed NCT03812614 - Comparative Effectiveness of Family vs. Individually Focused Diabetes Education and Support N/A
Completed NCT03650166 - High BP and Home Monitoring Experience (HoME) Study N/A
Recruiting NCT02908139 - Noninvasive Perioperative Monitoring of Arterial Stiffness, Volume and Nutritional Status in Stable Renal Transplant Recipients N/A
Completed NCT01622400 - Efficacy of a Dedicated Therapeutic Education Program in Patients at High Cardiovascular Risk N/A
Completed NCT00659672 - Effect of Whey Protein on Blood Pressure N/A
Completed NCT00473681 - Intervention Study to Control High Blood Pressure for Korean American N/A
Completed NCT03542240 - Effects of Curcumin Supplementation on Gut Barrier Function in Patients With Metabolic Syndrome N/A
Active, not recruiting NCT05526092 - OAT-GUT-BRAIN: Effects of Oats and Rice on Comprehensive Health of Metabolically Challenged Individuals N/A
Completed NCT02218931 - ESTEEM - Effect of Simple, Targeted Diet in Pregnant Women With Metabolic Risk Factors on Pregnancy Outcomes N/A
Recruiting NCT03753204 - Salt-Sensitivity and Immunity Cell Activation Phase 1/Phase 2
Not yet recruiting NCT04064281 - The Healthy Cantonese Diet on Cardiometabolic Syndrome N/A
Completed NCT04479384 - The Immediate Effect of an Osteopathic Manual Treatment on Blood Pressure in Adults With Hypertension - a Pilot Study. N/A
Completed NCT04082819 - MediBeat - HeartBeat Observation Trial N/A
Completed NCT03555344 - Effect of Mantra on Hypertensive Patients N/A
Withdrawn NCT03319823 - Treating Nocturnal Hypertension and Nocturia in African American Men Phase 4
Completed NCT00689819 - Pre-clinical Cardiac Dysfunction Among Asymptomatic Hypertensive Patients N/A
Completed NCT00417170 - Comparison of Aliskiren and Amlodipine on Insulin Resistance and Endothelial Dysfunction in Patients With Hypertension and Metabolic Syndrome Phase 2
Completed NCT00130156 - Effects of Combination Therapy With Alpha-1 Blocker (Bunazosin or Doxazosin) in the Treatment of Patients With Mild to Moderate Essential Hypertension Phase 4
Completed NCT05808556 - Sticker Pad Containing Essential Oil in Volunteer With High Blood Pressure N/A
Recruiting NCT05321368 - A Cardiometabolic Health Program Linked With Clinical-Community Support and Mobile Health Telemonitoring to Reduce Health Disparities N/A